Cleared Traditional

K843333 - SYSTEMATE GOT 67208

K843333 is the FDA 510(k) clearance for SYSTEMATE GOT 67208 by Em Diagnostic Systems, Inc.. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K843333 · Em Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
24d
Days
Class 2
Risk

K843333 is an FDA 510(k) clearance for the SYSTEMATE GOT 67208. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Em Diagnostic Systems, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 20, 1984 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Em Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K843333 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 1984
Decision Date September 20, 1984
Days to Decision 24 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 88d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 106
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K843333.
AMRESCO FLOW PAC SMA PHOSPHATE BUFFER CONCENTRATE
K851865 · Amresco, Inc. · May 1985
GEMENI AST-LTS REAGENTS
K851267 · Electro-Nucleonics Laboratories, Inc. · Apr 1985
ROCHE REAGENT FOR AST
K843109 · Roche Diagnostic Systems, Inc. · Nov 1984
SIGMA 58-UV ASPARTATE AMINOTRANSFERAS
K842411 · Sigma Chemical Co. · Aug 1984
ASPARTATE AMINOTRANSFERASE ASSAY KIT
K842245 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
SGOT-UV REAGENT SET
K841066 · Medical Specialties, Inc. · May 1984